Literature DB >> 16738492

Increased body weight in mice lacking mu-opioid receptors.

Wenhua Han1, Harumi Hata, Hiroki Imbe, Qing-Rong Liu, Yukio Takamatsu, Miwako Koizumi, Niall P Murphy, Emiko Senba, George R Uhl, Ichiro Sora, Kazutaka Ikeda.   

Abstract

Opioids have been suggested to affect feeding behaviour. To clarify the role of mu-opioid receptors in feeding, we measured several parameters relating to food intake in mu-opioid receptor knockout mice. Here, we show that the knockout mice had increased body weight in adulthood, although the intake amount of standard food was similar between the wild-type and knockout littermates. Serum markers for energy homeostasis were not significantly altered in the knockout mice. Hypothalamic neuropeptide Y mRNA, however, was higher in knockouts than in wild-type mice. Our results suggest that the up-regulated expression of neuropeptide Y mRNA might contribute to the increased weights of adult mu-opioid receptor knockout mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738492     DOI: 10.1097/01.wnr.0000221829.87974.ad

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  The MOR-1 opioid receptor regulates glucose homeostasis by modulating insulin secretion.

Authors:  Ting Wen; Bonnie Peng; John E Pintar
Journal:  Mol Endocrinol       Date:  2009-02-12

3.  Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Authors:  Aamir R Zuberi; Leigh Townsend; Laurel Patterson; Huiyuan Zheng; Hans-Rudi Berthoud
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

4.  Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor.

Authors:  Caitlin E Johnston; Daniel J Herschel; Amy W Lasek; Ronald P Hammer; Ella M Nikulina
Journal:  Neuropharmacology       Date:  2015-02       Impact factor: 5.250

5.  Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice.

Authors:  Ewa D Marczak; Yunden Jinsmaa; Page H Myers; Terry Blankenship; Ralph Wilson; Gianfranco Balboni; Severo Salvadori; Lawrence H Lazarus
Journal:  Eur J Pharmacol       Date:  2009-07-01       Impact factor: 4.432

6.  Mice lacking the G protein gamma3-subunit show resistance to opioids and diet induced obesity.

Authors:  William F Schwindinger; Brandon M Borrell; Lora C Waldman; Janet D Robishaw
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-16       Impact factor: 3.619

7.  Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry.

Authors:  Kazumasu Sasaki; Akira Sumiyoshi; Hiroi Nonaka; Yoshiyuki Kasahara; Kazutaka Ikeda; F Scott Hall; George R Uhl; Masahiko Watanabe; Ryuta Kawashima; Ichiro Sora
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

8.  Decreased consumption of sweet fluids in μ opioid receptor knockout mice: a microstructural analysis of licking behavior.

Authors:  Sean B Ostlund; Alisa Kosheleff; Nigel T Maidment; Niall P Murphy
Journal:  Psychopharmacology (Berl)       Date:  2013-04-09       Impact factor: 4.530

Review 9.  Persistent effects of obesity: a neuroplasticity hypothesis.

Authors:  Bridget A Matikainen-Ankney; Alexxai V Kravitz
Journal:  Ann N Y Acad Sci       Date:  2018-05-09       Impact factor: 5.691

10.  Mu opioid receptors on vGluT2-expressing glutamatergic neurons modulate opioid reward.

Authors:  Kaitlin C Reeves; Megan J Kube; Gregory G Grecco; Brandon M Fritz; Braulio Muñoz; Fuqin Yin; Yong Gao; David L Haggerty; Hunter J Hoffman; Brady K Atwood
Journal:  Addict Biol       Date:  2020-07-20       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.